ArticleBreast cancer (Tokyo, Japan)2021

miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers.

Yulei Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.